
Jean-Charles Soria/LinkedIn
Apr 27, 2025, 07:18
Jean-Charles Soria: ADC’s Bystander Effect may be crucial for efficacy
Jean-Charles Soria, SVP and Oncology Therapeutic Area Head of Amgen, shared an article by Zachary C. Hartman et al. on X:
“ADC’s Bystander Effect may be crucial for efficacy!
In a provocative recent paper, HER2 ADC’s payload may not need ADC internalization for efficacy !
Activity may rely on extracellular proteases, such as cathepsin L (CTSL). This extracellular release in the TME appears to kill nearby HER2-low/negative cancer cells.”
Authors: Li-Chung Tsao, Zachary C. Hartman, et al.
Journal: Nature Communications, April 2025
More posts featuring Jean-Charles Soria.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 27, 2025, 07:18
Apr 27, 2025, 05:33
Apr 27, 2025, 05:14
Apr 27, 2025, 03:52